Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux
about
Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause DwarfismA novel mutation in DDR2 causing spondylo-meta-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL) results in defective intra-cellular trafficking.Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patientsEndoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia.Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux.The cn/cn dwarf mouse. Histomorphometric, ultrastructural, and radiographic study in mutants corresponding to human acromesomelic dysplasia Maroteaux type (AMDM).Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.Disease-associated missense mutations in bestrophin-1 affect cellular trafficking and anion conductance.Catalytically active guanylyl cyclase-B requires glycosylation and mutations that inhibit this process cause dwarfism.The Absence of Sensory Axon Bifurcation Affects Nociception and Termination Fields of Afferents in the Spinal Cord.Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations.Endoplasmic reticulum retention of xylosyltransferase 1 (XYLT1) mutants underlying Desbuquois dysplasia type II
P2860
Q28116378-778942D9-BF21-436F-8B4D-F05308442F07Q31158465-1FB197D1-396A-43C3-B027-5D4FCE3B13E6Q33832884-87A9D2E1-D31D-4DB9-BD19-D4DA1E26D663Q34056160-D2B4B6E1-2D5C-4125-8E0A-E17AD2AE22CBQ34301501-A3EF425C-FD8A-4B6E-8D9D-D70735047369Q34446997-E2CC023D-0DC0-4596-9183-F8B41C64893DQ36867743-9636769C-E96C-4518-97BD-DDAFD6146D02Q39482100-105B695C-0B67-4085-B965-5E315C1D0A7DQ45914923-BD6805C1-B31D-4C71-A538-640C4EF42D36Q50280904-B9BAA73F-0892-47D1-9169-53EE2B613B9FQ50488360-088DBEFD-CBC6-4DBC-9205-6676A2556DFEQ56787142-1BBCD9A2-4B9B-4BE6-8685-5EC286038641
P2860
Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@ast
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@en
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@nl
type
label
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@ast
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@en
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@nl
prefLabel
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@ast
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@en
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@nl
P2093
P2860
P50
P356
P1476
Defective cellular trafficking ...... melic dysplasia-type Maroteaux
@en
P2093
Aydah M Al-Awadhi
Jens Buttgereit
Sarah S Al-Suwaidi
P2860
P304
P356
10.1093/HMG/DDN354
P407
P577
2009-01-15T00:00:00Z